Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.
The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period – using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. “When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period,” he said. “This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment,” added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. “Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation,” said Melov. “We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention.”
“Little has been known about the functional ramifications of rapamycin in mammalian tissues,” said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. “These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life.” He added, “It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life.”
The Latest Bing News on:
Age-Related Heart Disease
- Moderate to Heavy Drinking Tied to Increased Heart Disease Risk, Especially in Womenon March 28, 2024 at 2:46 pm
New studies show that women are more at risk than men of developing heart problems after the consumption of regular alcohol.
- More than one alcoholic drink a day raises heart disease risk for womenon March 28, 2024 at 6:56 am
The link between alcohol and coronary heart disease proved to be especially strong among women, new research showed.
- Multiomic approach boosts disease prediction accuracy beyond traditional methodson March 26, 2024 at 8:41 pm
Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer's, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome ...
- Coronary Heart Disease and Pregnancyon March 26, 2024 at 5:00 pm
Since women are delaying childbearing until older age, acute coronary syndrome ... the available information about pregnancy-related coronary heart disease. Yusuf Karamermer, Thorax Center ...
- 20 Countries with the Highest Heart Disease Deaths Per Capitaon March 26, 2024 at 4:20 am
In this article, we will be taking a look at the 20 countries with the highest disease deaths per capita. If you do not want to learn about the global heart disease landscape, head straight to the 5 ...
- Middle age's hidden perils — and possibilities — for the aging brainon March 23, 2024 at 3:53 am
Middle age is a tipping point for the brain and can offer clues about the risk of cognitive decline and dementia, emerging scientific evidence shows. Why it matters: The decades between 40 and 60 ...
- P.E. Teacher, 23, 'Felt Something Was Wrong' After First Marathon, Learns He Has Heart Disease a Week Later (Exclusive)on March 12, 2024 at 1:14 pm
“I was diagnosed with heart disease and had to have my heart procedure. I lived in fear the next month and a half to two months. I had so much fear, like, oh my goodness, I'm so young,” he recall ...
- Lupus and Heart Diseaseon March 7, 2024 at 4:00 pm
The risk of heart disease is much higher in people with lupus than in those without it. More than half of patients with SLE will get cardiovascular conditions related to their lupus. These include ...
- What Is Heart Disease? Symptoms, Causes, Diagnosis, Treatment, and Preventionon March 5, 2024 at 4:00 pm
Sometimes, structural heart defects can occur in adults as the heart’s structure changes with age. Researchers ... is closely related to heart disease, too. These episodes cause the sleeper ...
- Substance Use-Related Heart Disease Deaths Skyrocketed Over Past 20 Years, Study Findson January 10, 2024 at 2:10 am
A new study found substance use-related heart disease deaths ... The most common age range for substance use-related cardiovascular disease deaths was 55 to 69 (39.1%), followed by 40 to 54 ...
The Latest Google Headlines on:
Age-Related Heart Disease
[google_news title=”” keyword=”Age-Related Heart Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Rapamycin
- Study of Different Autism Types Finds Shared Mechanism That May Respond to Drugson March 28, 2024 at 6:58 am
Rutgers Health researchers detect similar disruptions in the neural development of genetic and unexplained autism.
- Can we really live forever?on March 26, 2024 at 4:00 am
In an age of remarkable scientific advances, three new books explore the prospects for living longer — and the challenges for human society ...
- Gen Alpha problems linked to parenting styles, tech: Educatoron March 25, 2024 at 8:45 pm
The decline of stabilizing institutions such as two-parent households and membership in religious congregations may compound the issue.
- AIMRC Seminar: Maximizing Health Span: The Synergy of Gerotherapeutic Drugs and Exerciseon March 25, 2024 at 7:44 am
Adam Konopka, assistant professor in the Department of Medicine, Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, will speak at 12:55 p.m. Wednesday in Gearhart Hall 108.
- ‘We could live past 120’: the scientist discovering why we dieon March 23, 2024 at 5:01 pm
Few people know more about how human life works than Cambridge’s Nobel prizewinning molecular biologist Venki Ramakrishnan. Now he’s pondering life’s most profound question ...
- How to ‘switch on’ your anti-ageing genes – and live longeron March 23, 2024 at 4:00 am
You’ve probably referred to them negatively – blaming them for your weight, bad habits or thinning hair. But while you can’t change the genetic hand you’ve been dealt, you actually have more control ...
- Sam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Bioscienceson March 23, 2024 at 2:46 am
Sam Altman started a $180 million side project called Retro Biosciences, hoping to add 10 healthy, enjoyable years onto the back end of our lifespans.
- Middle age: A critical turning point for brain health and cognitionon March 20, 2024 at 9:45 pm
Review emphasizes the significance of midlife for cognitive trajectories and brain health, advocating for research models that capture non-linear changes to better understand the unique processes ...
- Unique bacteria colonize the gut shortly after birth and make serotonin to educate gut immune cellson March 20, 2024 at 10:13 am
A recent study revealed that neonatal gut bacteria produce serotonin and down-regulate monoamine oxidase A (MOA) to limit serotonin breakdown, thereby promoting immune tolerance.
- How a cheap, generic drug became a darling of longevity enthusiastson March 15, 2024 at 11:56 am
Rapamycin, a drug for transplant patients, has extended the lives of animals but is unproven in humans. That hasn’t stopped people from trying it.
The Latest Google Headlines on:
Rapamycin
[google_news title=”” keyword=”rapamycin ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]